Fas	B-protein
ligation	O
induces	O
apoptosis	O
and	O
Jun	B-protein
kinase	I-protein
activation	O
independently	O
of	O
CD45	B-protein
and	O
Lck	B-protein
in	O
human	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

Stimulation	O
through	O
the	O
Fas/APO-1	B-protein
receptor	I-protein
results	O
in	O
apoptosis	O
through	O
an	O
incompletely	O
characterized	O
signaling	O
pathway	O
.	O

More	O
is	O
known	O
regarding	O
signal	O
transduction	O
events	O
that	O
occur	O
after	O
ligation	O
of	O
the	O
T-cell	B-protein
antigen	I-protein
receptor	I-protein
(	O
TCR	B-protein
)	O
.	O

It	O
has	O
been	O
shown	O
that	O
TCR	B-protein
stimulation	O
requires	O
both	O
the	O
membrane	B-protein
tyrosine	I-protein
phosphatase	I-protein
,	O
CD45	B-protein
,	O
and	O
the	O
Src-family	B-protein
kinase	I-protein
,	O
Lck	B-protein
,	O
to	O
result	O
in	O
cellular	O
activation	O
.	O

Although	O
prior	O
studies	O
suggest	O
a	O
role	O
for	O
protein	B-protein
tyrosine	I-protein
kinases	I-protein
and	O
phosphatases	O
in	O
Fas	B-protein
signaling	O
,	O
we	O
report	O
here	O
that	O
Fas	O
ligation	O
induces	O
apoptosis	O
in	O
T	B-cell_type
cells	I-cell_type
deficient	O
in	O
either	O
CD45	B-protein
or	O
Lck	B-protein
.	O

Further	O
,	O
in	O
normal	O
and	O
CD45-	B-cell_line
or	I-cell_line
Lck-deficient	I-cell_line
cell	I-cell_line
lines	I-cell_line
,	O
Fas	O
stimulation	O
results	O
in	O
activation	O
of	O
Jun	B-protein
kinase	I-protein
(	O
JNK	B-protein
)	O
,	O
a	O
proposed	O
mediator	O
of	O
stress	O
activation	O
pathways	O
.	O

Previous	O
studies	O
have	O
also	O
demonstrated	O
a	O
role	O
for	O
endogenous	O
ceramide	O
release	O
in	O
Fas-mediated	O
apoptosis	O
.	O

We	O
show	O
that	O
stimulation	O
with	O
a	O
synthetic	O
ceramide	O
analog	O
results	O
in	O
JNK	B-protein
activation	O
as	O
well	O
as	O
apoptosis	O
,	O
suggesting	O
ceramide	O
release	O
occurs	O
proximal	O
to	O
JNK	B-protein
activation	O
in	O
Fas	B-protein
signaling	O
.	O

Our	O
data	O
suggest	O
that	O
although	O
CD45	B-protein
and	O
Lck	B-protein
are	O
not	O
required	O
for	O
Fas	B-protein
signaling	O
,	O
JNK	B-protein
activation	O
may	O
play	O
an	O
important	O
role	O
transducing	O
distal	O
signals	O
that	O
lead	O
to	O
apoptosis	O
after	O
Fas	B-protein
ligation	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

RAPID	NULL
COMMUNICATION	NULL
Fas	NULL
Ligation	NULL
Induces	NULL
Apoptosis	NULL
and	NULL
Jun	NULL
Kinase	NULL
Activation	NULL
Independently	NULL
of	NULL
CD45	NULL
and	NULL
Lock	NULL
in	NULL
Human	NULL
T	NULL
Celis	NULL
By	NULL
Kevin	NULL
M.	NULL
Latinis	NULL
and	NULL
Gary	NULL
A.	NULL
Koretzky	NULL
Stimulation	NULL
through	NULL
the	NULL
Fas/APO-1	NULL
receptor	NULL
results	NULL
in	NULL
apoptosis	NULL
through	NULL
an	NULL
incompletely	NULL
characterized	NULL
signaling	NULL
pathway	NULL
.	NULL

More	NULL
is	NULL
known	NULL
regarding	NULL
signal	NULL
transduction	NULL
events	NULL
that	NULL
occur	NULL
after	NULL
ligation	NULL
of	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
TCR	NULL
stimulation	NULL
requires	NULL
both	NULL
the	NULL
membrane	NULL
tyrosine	NULL
phosphatase	NULL
,	NULL
CD45	NULL
,	NULL
and	NULL
the	NULL
Src-family	NULL
kinase	NULL
,	NULL
Lok	NULL
,	NULL
to	NULL
result	NULL
in	NULL
cellular	NULL
activation	NULL
.	NULL

Although	NULL
prior	NULL
studies	NULL
suggest	NULL
a	NULL
role	NULL
for	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
and	NULL
phosphatases	NULL
in	NULL
Fas	NULL
signaling	NULL
,	NULL
we	NULL
report	NULL
here	NULL
that	NULL
Fas	NULL
ligation	NULL
induces	NULL
apoptosis	NULL
in	NULL
T	NULL
cells	NULL
deficient	NULL
in	NULL
either	NULL
CD45	NULL
or	NULL
Lock	NULL
.	NULL

Further	NULL
,	NULL
in	NULL
normal	NULL
and	NULL
CD45-	NULL
or	NULL
Lok-deficient	NULL
cell	NULL
lines	NULL
,	NULL
Fas	NULL
stimulation	NULL
results	NULL
in	NULL
activation	NULL
of	NULL
Jun	NULL
kinase	NULL
(	NULL
JNK	NULL
)	NULL
,	NULL
a	NULL
HE	NULL
Fas	NULL
(	NULL
APO-1	NULL
,	NULL
CD95	NULL
)	NULL
surface	NULL
receptor	NULL
is	NULL
known	NULL
to	NULL
be	NULL
an	NULL
important	NULL
mediator	NULL
of	NULL
apoptosis	NULL
in	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
.	NULL

``	NULL
*	NULL
Apoptosis	NULL
stimulated	NULL
via	NULL
Fas	NULL
ligation	NULL
is	NULL
characterized	NULL
by	NULL
cytoplasmic	NULL
and	NULL
nuclear	NULL
condensation	NULL
and	NULL
DNA	NULL
fragmentation	NULL
.	NULL

``	NULL
*	NULL
``	NULL
The	NULL
physiologic	NULL
importance	NULL
of	NULL
Fas	NULL
is	NULL
evident	NULL
from	NULL
both	NULL
murine	NULL
and	NULL
human	NULL
studies	NULL
showing	NULL
that	NULL
mutations	NULL
in	NULL
Fas	NULL
result	NULL
in	NULL
lymphoproliferative	NULL
disorders	NULL
and	NULL
autoimmune	NULL
disease	NULL
.	NULL
``	NULL

''	NULL
Other	NULL
studies	NULL
also	NULL
support	NULL
the	NULL
hypothesis	NULL
that	NULL
Fas	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
process	NULL
of	NULL
immune	NULL
peripheral	NULL
tolerance	NULL
.	NULL

``	NULL
!	NULL

Yet	NULL
,	NULL
despite	NULL
convincing	NULL
data	NULL
supporting	NULL
the	NULL
physiologic	NULL
importance	NULL
of	NULL
Fas	NULL
,	NULL
relatively	NULL
little	NULL
is	NULL
known	NULL
regarding	NULL
how	NULL
Fas	NULL
transmits	NULL
its	NULL
intracellular	NULL
signals	NULL
.	NULL

Fas	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
receptor	NULL
family	NULL
.	NULL
``	NULL

''	NULL
It	NULL
contains	NULL
a	NULL
cysteine-rich	NULL
extracellular	NULL
domain	NULL
that	NULL
mediates	NULL
its	NULL
binding	NULL
to	NULL
Fas	NULL
Ligand**	NULL
``	NULL
and	NULL
an	NULL
intracellular	NULL
``	NULL
'death	NULL
domain	NULL
``	NULL
required	NULL
to	NULL
promote	NULL
cell	NULL
death	NULL
.	NULL
``	NULL

''	NULL
Although	NULL
Fas	NULL
lacks	NULL
intrinsic	NULL
catalytic	NULL
activity	NULL
,	NULL
several	NULL
reports	NULL
have	NULL
described	NULL
Fas-associated	NULL
proteins	NULL
proposed	NULL
to	NULL
function	NULL
as	NULL
signaling	NULL
intermediates	NULL
.	NULL
``	NULL

Both	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
(	NULL
PTK	NULL
)	NULL
and	NULL
protein	NULL
tyrosine	NULL
phosphatase	NULL
(	NULL
PTPase	NULL
)	NULL
activity	NULL
are	NULL
indispensable	NULL
for	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
mediated	NULL
activation	NULL
.	NULL

'**	NULL
``	NULL
A	NULL
recent	NULL
study	NULL
suggested	NULL
that	NULL
PTK	NULL
and	NULL
PTPase	NULL
also	NULL
participate	NULL
in	NULL
early	NULL
signaling	NULL
events	NULL
mediated	NULL
by	NULL
Fas	NULL
.	NULL
``	NULL

In	NULL
this	NULL
report	NULL
,	NULL
ligation	NULL
of	NULL
Fas	NULL
was	NULL
shown	NULL
to	NULL
result	NULL
in	NULL
a	NULL
rapid	NULL
increase	NULL
in	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
.	NULL
``	NULL

Additionally	NULL
,	NULL
Fas	NULL
possesses	NULL
a	NULL
unique	NULL
carboxy-terminal	NULL
domain	NULL
shown	NULL
to	NULL
be	NULL
important	NULL
for	NULL
interactions	NULL
with	NULL
PTP-BAS	NULL
(	NULL
FAP-1	NULL
)	NULL
,	NULL
a	NULL
tyrosine	NULL
phosphatase	NULL
whose	NULL
expression	NULL
appears	NULL
to	NULL
correlate	NULL
with	NULL
inhibition	NULL
of	NULL
Fas-mediated	NULL
killing	NULL
.	NULL
``	NULL

In	NULL
this	NULL
report	NULL
we	NULL
describe	NULL
experiments	NULL
designed	NULL
to	NULL
examine	NULL
whether	NULL
the	NULL
protein	NULL
tyrosine	NULL
phosphatase	NULL
,	NULL
CD45	NULL
,	NULL
or	NULL
the	NULL
Src-family	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
,	NULL
Lck	NULL
,	NULL
are	NULL
required	NULL
for	NULL
Fas-induced	NULL
apoptosis	NULL
in	NULL
the	NULL
Jurkat	NULL
leukemic	NULL
T-cell	NULL
line	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
neither	NULL
CD45	NULL
nor	NULL
Leck	NULL
expression	NULL
is	NULL
required	NULL
for	NULL
Fas	NULL
to	NULL
couple	NULL
with	NULL
its	NULL
signaling	NULL
machinery	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Several	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
Jun	NULL
kinase	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
mediating	NULL
the	NULL
cytotoxic	NULL
effects	NULL
after	NULL
TNF	NULL
receptor	NULL
ligation	NULL
.	NULL
``	NULL

Additionally	NULL
,	NULL
both	NULL
TNF	NULL
and	NULL
Fas	NULL
receptor	NULL
stimulation	NULL
result	NULL
in	NULL
increased	NULL
sphingomyelinase	NULL
activity	NULL
and	NULL
subsequent	NULL
intracellular	NULL
ceramide	NULL
release	NULL
.	NULL
``	NULL

''	NULL
Synthetic	NULL
ceramide	NULL
analogs	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
apoptosis	NULL
independently	NULL
Blood	NULL
,	NULL
Vol	NULL
87	NULL
,	NULL
No	NULL
3	NULL
(	NULL
February	NULL
1	NULL
)	NULL
,	NULL
1996	NULL
:	NULL
pp	NULL
871-875	NULL
proposed	NULL
mediator	NULL
of	NULL
stress	NULL
activation	NULL
pathways	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
also	NULL
demonstrated	NULL
a	NULL
role	NULL
for	NULL
endogenous	NULL
ceramide	NULL
release	NULL
in	NULL
Fas-mediated	NULL
apoptosis	NULL
.	NULL

We	NULL
show	NULL
that	NULL
stimulation	NULL
with	NULL
a	NULL
synthetic	NULL
ceramide	NULL
analog	NULL
results	NULL
in	NULL
JNK	NULL
activation	NULL
as	NULL
well	NULL
as	NULL
apoptosis	NULL
,	NULL
suggesting	NULL
ceramide	NULL
release	NULL
occurs	NULL
proximal	NULL
to	NULL
JNK	NULL
activation	NULL
in	NULL
Fas	NULL
signaling	NULL
.	NULL

Our	NULL
data	NULL
suggest	NULL
that	NULL
although	NULL
CD45	NULL
and	NULL
Lock	NULL
are	NULL
not	NULL
required	NULL
for	NULL
Fas	NULL
signaling	NULL
,	NULL
JNK	NULL
activation	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
transducing	NULL
distal	NULL
signals	NULL
that	NULL
lead	NULL
to	NULL
apoptosis	NULL
after	NULL
Fas	NULL
ligation	NULL
.	NULL

Â©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

of	NULL
receptor	NULL
ligation	NULL
,	NULL
``	NULL
suggesting	NULL
a	NULL
role	NULL
for	NULL
the	NULL
sphingomy-	NULL
elinase	NULL
pathway	NULL
in	NULL
transducing	NULL
apoptotic	NULL
signals	NULL
.	NULL

Our	NULL
data	NULL
indicate	NULL
that	NULL
both	NULL
Fas	NULL
ligation	NULL
and	NULL
treatment	NULL
with	NULL
synthetic	NULL
ceramide	NULL
analogs	NULL
result	NULL
in	NULL
JNK	NULL
activation	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
ceramide	NULL
release	NULL
occurs	NULL
proximal	NULL
to	NULL
increased	NULL
JNK	NULL
activity	NULL
following	NULL
Fas	NULL
stimulation	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
.	NULL

-	NULL
The	NULL
human	NULL
leukemic	NULL
T-cell	NULL
line	NULL
Jurkat	NULL
,	NULL
a	NULL
CD45-deficient	NULL
derivative	NULL
,	NULL
J45.01	NULL
,	NULL
``	NULL
Â°	NULL
and	NULL
an	NULL
Lck-deficient	NULL
derivative	NULL
,	NULL
JCaM.1	NULL
,	NULL
*	NULL
``	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
penicillin	NULL
(	NULL
1,000	NULL
U/mL	NULL
)	NULL
,	NULL
streptomycin	NULL
(	NULL
1,000	NULL
U/mL	NULL
)	NULL
,	NULL
and	NULL
glutamine	NULL
(	NULL
20	NULL
mmol/L	NULL
)	NULL
.	NULL

Reagents	NULL
,	NULL
antibodies	NULL
,	NULL
and	NULL
GST	NULL
fusion	NULL
proteins	NULL
.	NULL

The	NULL
following	NULL
reagents	NULL
were	NULL
used	NULL
in	NULL
this	NULL
study	NULL
:	NULL
propidium	NULL
iodide	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
,	NULL
D-sorbitol	NULL
(	NULL
Fisher	NULL
Scientific	NULL
,	NULL
Pitts-burgh	NULL
,	NULL
PA	NULL
)	NULL
,	NULL
[	NULL
y-P	NULL
]	NULL
ATP	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
and	NULL
C2-ceramide	NULL
(	NULL
Calbiochem	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
following	NULL
antibodies	NULL
were	NULL
used	NULL
in	NULL
this	NULL
study	NULL
:	NULL
nonspecific	NULL
control	NULL
IgG	NULL
monoclonal	NULL
antibody	NULL
(	NULL
MoAb	NULL
)	NULL
,	NULL
MOPC-195	NULL
(	NULL
Cappel	NULL
,	NULL
Durham	NULL
,	NULL
NC	NULL
)	NULL
;	NULL
anti-CD3	NULL
MoAb	NULL
,	NULL
OKT3	NULL
(	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
;	NULL
anti-CD45	NULL
MoAb	NULL
,	NULL
9.4	NULL
(	NULL
ATCC	NULL
)	NULL
;	NULL
and	NULL
anti-Fas	NULL
MoAb	NULL
,	NULL
CH11	NULL
(	NULL
Upstate	NULL
Biotechnology	NULL
,	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

The	NULL
pGEX-GST	NULL
c-Jun	NULL
(	NULL
1-79	NULL
)	NULL
plasmid	NULL
was	NULL
a	NULL
gift	NULL
of	NULL
Dr	NULL
Jeffrey	NULL
Pessin	NULL
(	NULL
Iowa	NULL
City	NULL
,	NULL
IA	NULL
)	NULL
.	NULL

GST	NULL
c-Jun	NULL
(	NULL
1-79	NULL
)	NULL
fusion	NULL
protein	NULL
was	NULL
expressed	NULL
and	NULL
affinity	NULL
purified	NULL
using	NULL
glutathione-agarose	NULL
beads	NULL
(	NULL
Sigma	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
as	NULL
described	NULL
.	NULL
``	NULL

From	NULL
the	NULL
Departments	NULL
of	NULL
Immunology	NULL
and	NULL
Internal	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Iowa	NULL
,	NULL
Iowa	NULL
City	NULL
.	NULL

Submitted	NULL
October	NULL
10	NULL
,	NULL
1995	NULL
;	NULL
accepted	NULL
November	NULL
7	NULL
,	NULL
1995	NULL
.	NULL

Supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
No	NULL
.	NULL

CA-56843	NULL
(	NULL
to	NULL
G.A.K	NULL
.	NULL
)	NULL

,	NULL
the	NULL
Carver	NULL
Trust	NULL
at	NULL
the	NULL
University	NULL
of	NULL
Iowa	NULL
(	NULL
to	NULL
G.A.K	NULL
.	NULL
)	NULL

,	NULL
and	NULL
the	NULL
National	NULL
Institute	NULL
of	NULL
Aging	NULL
predoctoral	NULL
National	NULL
Research	NULL
Service	NULL
Award	NULL
Grant	NULL
No	NULL
.	NULL

AG-00214	NULL
(	NULL
to	NULL
K.M.L	NULL
.	NULL
)	NULL

.	NULL

G.A.K	NULL
.	NULL

is	NULL
an	NULL
Established	NULL
Investigator	NULL
of	NULL
the	NULL
American	NULL
Heart	NULL
Association	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Gary	NULL
A.	NULL
Koretzky	NULL
,	NULL
MD	NULL
,	NULL
PhD	NULL
,	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
540	NULL
Eckstein	NULL
Medical	NULL
Research	NULL
Bldg	NULL
,	NULL
University	NULL
of	NULL
Iowa	NULL
,	NULL
lowa	NULL
City	NULL
,	NULL
IA	NULL
52242	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

Â©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
1/96/8703-0045	NULL
$	NULL
3.00/0	NULL
871	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

872	NULL
Fluorescence-activated	NULL
cell	NULL
sorter	NULL
(	NULL
FACS	NULL
)	NULL
analysis	NULL
.	NULL

TCR	NULL
and	NULL
CD45	NULL
surface	NULL
expression	NULL
was	NULL
determined	NULL
by	NULL
staining	NULL
cells	NULL
with	NULL
IgG-negative	NULL
control	NULL
MoAb	NULL
,	NULL
MOPC	NULL
,	NULL
anti-CD3	NULL
MoAb	NULL
,	NULL
OKT3	NULL
,	NULL
or	NULL
anti-CD45	NULL
MoAb	NULL
,	NULL
9.4	NULL
,	NULL
for	NULL
30	NULL
minutes	NULL
followed	NULL
by	NULL
fluorescein	NULL
isothiocyanate-conjugated	NULL
goat	NULL
(	NULL
Fab	NULL
'	NULL
2	NULL
)	NULL
antimouse	NULL
IgG	NULL
(	NULL
Cappel	NULL
,	NULL
Durham	NULL
,	NULL
NC	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
.	NULL

Fas	NULL
surface	NULL
expression	NULL
was	NULL
determined	NULL
by	NULL
incubating	NULL
cells	NULL
with	NULL
anti-Fas	NULL
MoAb	NULL
,	NULL
CH11	NULL
,	NULL
for	NULL
30	NULL
minutes	NULL
followed	NULL
by	NULL
fluorescein	NULL
isothiocyanate-conjugated	NULL
goat-antimouse	NULL
IgM	NULL
(	NULL
Cappel	NULL
)	NULL
.	NULL

Stained	NULL
cells	NULL
were	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
(	NULL
FACScan	NULL
;	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
using	NULL
Lysis	NULL
II	NULL
software	NULL
(	NULL
Becton	NULL
Dickin-son	NULL
)	NULL
.	NULL

Propidium	NULL
iodide	NULL
exclusion	NULL
assays	NULL
.	NULL

Assays	NULL
were	NULL
done	NULL
as	NULL
described	NULL
.	NULL
``	NULL

Briefly	NULL
,	NULL
2	NULL
X	NULL
10Â°	NULL
cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
for	NULL
16	NULL
hours	NULL
with	NULL
Fas	NULL
MoAb	NULL
,	NULL
CH11	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
,	NULL
or	NULL
C2-ceramide	NULL
(	NULL
40	NULL
amol/L	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
pelleted	NULL
and	NULL
resuspended	NULL
in	NULL
0.4	NULL
mL	NULL
of	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
supplemented	NULL
with	NULL
1	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
0.02	NULL
%	NULL
sodium	NULL
azide	NULL
,	NULL
and	NULL
1	NULL
%	NULL
propidium	NULL
iodide	NULL
and	NULL
then	NULL
analyzed	NULL
by	NULL
FACS	NULL
using	NULL
a	NULL
FACScan	NULL
and	NULL
Lysis	NULL
II	NULL
software	NULL
.	NULL

Percent	NULL
cell	NULL
death	NULL
was	NULL
determined	NULL
by	NULL
dividing	NULL
the	NULL
number	NULL
of	NULL
cells	NULL
that	NULL
incorporated	NULL
propidium	NULL
iodide	NULL
by	NULL
the	NULL
total	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

DNA	NULL
fragmentation	NULL
analysis	NULL
.	NULL

-	NULL
Cells	NULL
,	NULL
2	NULL
X	NULL
10Â°	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
as	NULL
described	NULL
for	NULL
propidium	NULL
iodide	NULL
exclusion	NULL
assay	NULL
.	NULL

Cell	NULL
lysates	NULL
prepared	NULL
in	NULL
200	NULL
gL	NULL
hypotonic	NULL
lysis	NULL
buffer	NULL
(	NULL
10	NULL
mmol/L	NULL
Tris-HCl	NULL
pH	NULL
8.0	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
0.2	NULL
%	NULL
Triton	NULL
X-100	NULL
)	NULL
for	NULL
10	NULL
minutes	NULL
(	NULL
4Â°C	NULL
)	NULL
and	NULL
cleared	NULL
by	NULL
centrifugation	NULL
for	NULL
15	NULL
minutes	NULL
were	NULL
subjected	NULL
to	NULL
DNA	NULL
precipitation	NULL
by	NULL
treating	NULL
with	NULL
400	NULL
uL	NULL
100	NULL
%	NULL
EIOH	NULL
and	NULL
40	NULL
uL	NULL
5	NULL
mol/L	NULL
NaC	NULL
)	NULL
at	NULL
-70Â°C	NULL
for	NULL
2	NULL
hours	NULL
.	NULL

Samples	NULL
were	NULL
centrifuged	NULL
at	NULL
4Â°C	NULL
,	NULL
pellets	NULL
washed	NULL
with	NULL
70	NULL
%	NULL
EtOH	NULL
,	NULL
and	NULL
dried	NULL
.	NULL

DNA	NULL
pellets	NULL
were	NULL
then	NULL
resuspended	NULL
in	NULL
25	NULL
gL	NULL
TE	NULL
buffer	NULL
followed	NULL
by	NULL
electrophoresis	NULL
in	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
.	NULL

DNA	NULL
bands	NULL
were	NULL
visualized	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
and	NULL
UV	NULL
light	NULL
illumination	NULL
.	NULL

Jun	NULL
kinase	NULL
assay	NULL
.	NULL

-	NULL
In	NULL
vitro	NULL
JNK	NULL
activity	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
.	NULL
``	NULL

Briefly	NULL
,	NULL
1	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
PBS	NULL
and	NULL
resuspended	NULL
in	NULL
200	NULL
uL	NULL
PBS	NULL
.	NULL

Cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
MoAb	NULL
CHH	NULL
(	NULL
2	NULL
pg/mL	NULL
)	NULL
or	NULL
C2-ceramide	NULL
(	NULL
40	NULL
pmol/L	NULL
)	NULL
for	NULL
2	NULL
minutes	NULL
,	NULL
10	NULL
minutes	NULL
,	NULL
and	NULL
30	NULL
minutes	NULL
or	NULL
with	NULL
D-Sorbitol	NULL
(	NULL
0.6	NULL
mol/L	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
37Â°C	NULL
followed	NULL
by	NULL
lysis	NULL
in	NULL
JNK	NULL
lysis	NULL
buffer	NULL
(	NULL
50	NULL
mmoV/L	NULL
HEPES	NULL
pH	NULL
7.8	NULL
,	NULL
0.3	NULL
mol/L	NULL
NaCl	NULL
,	NULL
1.5	NULL
mmol/L	NULL
MgCl	NULL
,	NULL
,	NULL
1.2	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
20	NULL
mmol/L	NULL
3-glycerophosphate	NULL
,	NULL
100	NULL
mmol/L	NULL
NaF	NULL
,	NULL
10	NULL
mmol/L	NULL
Na	NULL
pyrophosphate	NULL
,	NULL
0.1	NULL
mmol/L	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
,	NULL
1	NULL
mmol/L	NULL
phenyImethyisulfonyl	NULL
fluoride	NULL
,	NULL
2	NULL
umol/L	NULL
pepstatin	NULL
,	NULL
2	NULL
ug/	NULL
mL	NULL
aprotinin	NULL
,	NULL
1	NULL
pg/mL	NULL
leupeptin	NULL
)	NULL
.	NULL

Lysates	NULL
were	NULL
cleared	NULL
by	NULL
centrifugation	NULL
for	NULL
10	NULL
minutes	NULL
at	NULL
4Â°C	NULL
and	NULL
incubated	NULL
with	NULL
GST	NULL
c-Jun	NULL
(	NULL
1-79	NULL
)	NULL
for	NULL
2	NULL
hours	NULL
at	NULL
4Â°C	NULL
.	NULL

The	NULL
fusion	NULL
protein	NULL
complexes	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
in	NULL
30	NULL
gL	NULL
of	NULL
kinase	NULL
reaction	NULL
mixture	NULL
(	NULL
20	NULL
mmol/L	NULL
HEPES	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
,	NULL
20	NULL
mmol/L	NULL
MgCl	NULL
;	NULL
,	NULL
20	NULL
mmol/L	NULL
@	NULL
-glycerophosphate	NULL
,	NULL
0.1	NULL
mmol/L	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
,	NULL
2	NULL
mmol/L	NULL
DTT	NULL
,	NULL
20	NULL
pmol/L	NULL
ATP	NULL
,	NULL
and	NULL
5	NULL
(	NULL
0.5	NULL
Ci	NULL
for	NULL
Fig	NULL
4	NULL
)	NULL
[	NULL
y-P	NULL
]	NULL
JATP	NULL
.	NULL

Reactions	NULL
were	NULL
stopped	NULL
by	NULL
adding	NULL
30	NULL
pL	NULL
of	NULL
Laemmili	NULL
's	NULL
sample	NULL
buffer	NULL
and	NULL
boiling	NULL
and	NULL
then	NULL
resolved	NULL
by	NULL
10	NULL
%	NULL
sodium	NULL
dodecyt	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
stained	NULL
with	NULL
Coomassie	NULL
Brilliant	NULL
Blue	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
autoradiography	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
Jurkat	NULL
,	NULL
145.01	NULL
,	NULL
and	NULL
JCaM.1	NULL
express	NULL
equivalent	NULL
amounts	NULL
of	NULL
Fas	NULL
.	NULL

-	NULL
The	NULL
Jurkat	NULL
T-lymphocyte	NULL
leukemic	NULL
cell	NULL
line	NULL
served	NULL
as	NULL
a	NULL
model	NULL
cell	NULL
for	NULL
all	NULL
experiments	NULL
in	NULL
this	NULL
study	NULL
.	NULL

To	NULL
investigate	NULL
possible	NULL
roles	NULL
of	NULL
CD45	NULL
and	NULL
Lok	NULL
in	NULL
Fas	NULL
signaling	NULL
,	NULL
experiments	NULL
were	NULL
performed	NULL
using	NULL
CD45-	NULL
and	NULL
Lek-deficient	NULL
derivatives	NULL
of	NULL
Jurkat	NULL
.	NULL

Relative	NULL
surface	NULL
expression	NULL
of	NULL
T-cell	NULL
receptor	NULL
,	NULL
CD45	NULL
,	NULL
and	NULL
Fas	NULL
was	NULL
evaluated	NULL
by	NULL
FACS	NULL
analysis	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

All	NULL
three	NULL
cell	NULL
lines	NULL
expressed	NULL
equivalent	NULL
amounts	NULL
of	NULL
Fas	NULL
and	NULL
TCR	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
145.01	NULL
cells	NULL
expressed	NULL
much	NULL
less	NULL
CD45	NULL
than	NULL
either	NULL
Jurkat	NULL
or	NULL
JCaM.1	NULL
cells	NULL
.	NULL

This	NULL
low	NULL
level	NULL
LATINIS	NULL
AND	NULL
KORETZKY	NULL
JURKAT	NULL
150	NULL
MOPC	NULL
-	NULL
_-	NULL
150	NULL
a	NULL
TCR	NULL
--	NULL
--	NULL
150	NULL
Relative	NULL
Cell	NULL
Number	NULL
150	NULL
a	NULL
weil	NULL
cil	NULL
-~	NULL
[	NULL
PE	NULL
i	NULL
--	NULL
~	NULL
10Â°	NULL
Log	NULL
Fluorescence	NULL
Intensity	NULL
Fig	NULL
1	NULL
.	NULL

-	NULL
Phenotypic	NULL
analysis	NULL
of	NULL
Jurkat	NULL
,	NULL
445.01	NULL
,	NULL
and	NULL
JCaM.1	NULL
.	NULL

Surface	NULL
protein	NULL
expression	NULL
was	NULL
determined	NULL
by	NULL
incubating	NULL
cells	NULL
with	NULL
the	NULL
IgG-negative	NULL
control	NULL
MoAb	NULL
,	NULL
MOPC-195	NULL
;	NULL
anti-CD3	NULL
specific	NULL
MoAb	NULL
,	NULL
OKT3	NULL
;	NULL
or	NULL
anti-Fas	NULL
specific	NULL
MoAb	NULL
,	NULL
CH11	NULL
,	NULL
followed	NULL
by	NULL
an	NULL
FITC-conjugated	NULL
secondary	NULL
antibody	NULL
and	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

As	NULL
a	NULL
control	NULL
for	NULL
the	NULL
anti-Fas	NULL
IgM	NULL
MoAb	NULL
,	NULL
cells	NULL
were	NULL
also	NULL
analyzed	NULL
with	NULL
secondary	NULL
antibody	NULL
only	NULL
(	NULL
No	NULL
1Â°	NULL
)	NULL
.	NULL

Jurkat	NULL
,	NULL
J45.01	NULL
,	NULL
and	NULL
JCaM.1	NULL
express	NULL
equivalent	NULL
amounts	NULL
of	NULL
TCR	NULL
and	NULL
Fas	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
J45.01	NULL
express	NULL
greatly	NULL
reduced	NULL
amounts	NULL
of	NULL
CD45	NULL
.	NULL

of	NULL
CD45	NULL
has	NULL
been	NULL
shown	NULL
previously	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
diminished	NULL
proximal	NULL
signaling	NULL
events	NULL
through	NULL
the	NULL
TCR	NULL
by	NULL
preventing	NULL
tyrosine	NULL
kinase	NULL
activation	NULL
.	NULL
'	NULL

''	NULL
``	NULL
Similarly	NULL
,	NULL
JCaM.1	NULL
cells	NULL
lack	NULL
expression	NULL
of	NULL
the	NULL
56-kD	NULL
protein	NULL
,	NULL
Lok	NULL
.	NULL
``	NULL

The	NULL
absence	NULL
of	NULL
Lck	NULL
also	NULL
is	NULL
responsible	NULL
for	NULL
diminished	NULL
proximal	NULL
signaling	NULL
events	NULL
after	NULL
TCR	NULL
ligation	NULL
.	NULL
``	NULL

Fas	NULL
ligation	NULL
results	NULL
in	NULL
apoptosis	NULL
in	NULL
Jurkat	NULL
,	NULL
145.01	NULL
,	NULL
and	NULL
JCaM.1	NULL
.	NULL

-	NULL
To	NULL
assess	NULL
directly	NULL
the	NULL
importance	NULL
of	NULL
either	NULL
CD45	NULL
or	NULL
Lok	NULL
in	NULL
transducing	NULL
death	NULL
signals	NULL
through	NULL
Fas	NULL
,	NULL
Jurkat	NULL
,	NULL
145.01	NULL
,	NULL
and	NULL
JCaM.1	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
an	NULL
agonistic	NULL
antibody	NULL
against	NULL
Fas	NULL
for	NULL
16	NULL
hours	NULL
and	NULL
assayed	NULL
for	NULL
cell	NULL
death	NULL
by	NULL
propidium	NULL
iodide	NULL
incorporation	NULL
.	NULL

We	NULL
observed	NULL
no	NULL
significant	NULL
difference	NULL
in	NULL
Fas	NULL
killing	NULL
between	NULL
wild-type	NULL
Jurkat	NULL
and	NULL
the	NULL
CD45-deficient	NULL
or	NULL
Lck-deficient	NULL
derivatives	NULL
.	NULL

Figure	NULL
2A	NULL
is	NULL
representative	NULL
of	NULL
five	NULL
independent	NULL
experiments	NULL
.	NULL

Detailed	NULL
time-course	NULL
and	NULL
dose-response	NULL
experiments	NULL
as	NULL
well	NULL
as	NULL
TUNEL	NULL
(	NULL
TdT	NULL
dUTP	NULL
nicked	NULL
end-labeling	NULL
)	NULL
analysis	NULL
,	NULL
a	NULL
quanti-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Fas	NULL
SIGNALING	NULL
DOES	NULL
NOT	NULL
REQUIRE	NULL
CD45	NULL
OR	NULL
Lck	NULL
A	NULL
100	NULL
907	NULL
8	NULL
0	NULL
Jurkat	NULL
J45.01	NULL
JCaM.1	NULL
707	NULL
607	NULL
T	NULL
iki	NULL
T	NULL
T	NULL
40	NULL
%	NULL
of	NULL
Cell	NULL
Death	NULL
307	NULL
2	NULL
0	NULL
7	NULL
107	NULL
o	NULL
NS	NULL
anti-Fas	NULL
NS	NULL
anti-Fas	NULL
NS	NULL
anti-Fas	NULL
*	NULL
A	NULL
A	NULL
B	NULL
039	NULL
4:9	NULL
0	NULL
&	NULL
3	NULL
``	NULL
'	NULL
>	NULL
py	NULL
Anti-Fas	NULL
:	NULL
-	NULL
+	NULL
--	NULL
+	NULL
s	NULL
Fig	NULL
2	NULL
.	NULL

Fas	NULL
ligation	NULL
stimulates	NULL
apoptosis	NULL
in	NULL
Jurkat	NULL
,	NULL
J45.01	NULL
and	NULL
JCaM.1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
for	NULL
16	NULL
hours	NULL
with	NULL
anti-Fas	NULL
MoAb	NULL
,	NULL
CH11	NULL
.	NULL

Cell	NULL
death	NULL
was	NULL
then	NULL
analyzed	NULL
by	NULL
propidium	NULL
iodide	NULL
incorporation	NULL
.	NULL

Percent	NULL
cell	NULL
death	NULL
was	NULL
calculated	NULL
as	NULL
the	NULL
number	NULL
of	NULL
cells	NULL
incorporating	NULL
propidium	NULL
iodide	NULL
divided	NULL
by	NULL
total	NULL
cell	NULL
count	NULL
.	NULL

Jurkat	NULL
,	NULL
J45.01	NULL
,	NULL
and	NULL
JCaM.1	NULL
all	NULL
responded	NULL
similarly	NULL
to	NULL
anti-Fas	NULL
treatment	NULL
by	NULL
increasing	NULL
the	NULL
proportion	NULL
of	NULL
cell	NULL
death	NULL
.	NULL

Results	NULL
are	NULL
the	NULL
mean	NULL
of	NULL
five	NULL
independent	NULL
experiments	NULL
+	NULL
SEM	NULL
.	NULL

Student	NULL
's	NULL
t-test	NULL
was	NULL
performed	NULL
between	NULL
unstimulated	NULL
and	NULL
anti-Fas	NULL
stimulated	NULL
trials	NULL
for	NULL
Jurkat	NULL
,	NULL
J45.01	NULL
,	NULL
and	NULL
JCaM.1	NULL
:	NULL
P	NULL
=	NULL
.002	NULL
,	NULL
P	NULL
=	NULL
.00008	NULL
,	NULL
P	NULL
=	NULL
.004	NULL
,	NULL
respec-tively	NULL
.	NULL

NS	NULL
,	NULL
not	NULL
stimulated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
DNA	NULL
fragmentation	NULL
analysis	NULL
of	NULL
Jurkat	NULL
,	NULL
145.01	NULL
,	NULL
and	NULL
JCaM.1	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
as	NULL
above	NULL
followed	NULL
by	NULL
isolation	NULL
of	NULL
cellular	NULL
DNA	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

DNA	NULL
was	NULL
separated	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
and	NULL
visualized	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
and	NULL
UV	NULL
light	NULL
illumination	NULL
.	NULL

Fragmentation	NULL
of	NULL
DNA	NULL
into	NULL
approximately	NULL
200-bp	NULL
concatamers	NULL
occurred	NULL
in	NULL
all	NULL
three	NULL
cell	NULL
lines	NULL
following	NULL
anti-Fas	NULL
stimulation	NULL
.	NULL

873	NULL
A	NULL
0	NULL
8	NULL
-	NULL
(	NULL
Â¥	NULL
I-41	NULL
Jurkat	NULL
%	NULL
<	NULL
4	NULL
&	NULL
-	NULL
GSTe-Jun	NULL
M	NULL
250900	NULL
30	NULL
30Â°	NULL
A	NULL
a	NULL
I	NULL
Â«	NULL
8	NULL
_	NULL
J45.01|	NULL
JCaM	NULL
.	NULL

1	NULL
+	NULL
0	NULL
Fig	NULL
3	NULL
.	NULL

JNK	NULL
is	NULL
activated	NULL
in	NULL
Jurkat	NULL
,	NULL
J45.01	NULL
,	NULL
and	NULL
JCaM.1	NULL
after	NULL
anti-Fas	NULL
stimulation	NULL
.	NULL

Lysates	NULL
prepared	NULL
from	NULL
unstimulated	NULL
or	NULL
Fas	NULL
stimulated	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
recombinant	NULL
GST	NULL
c-Jun	NULL
fusion	NULL
protein	NULL
and	NULL
the	NULL
resulting	NULL
protein	NULL
complexes	NULL
were	NULL
subjected	NULL
to	NULL
an	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
with	NULL
[	NULL
y-*Â°P	NULL
]	NULL
ATP	NULL
,	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

Sorbitol	NULL
stimulation	NULL
served	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
in	NULL
all	NULL
three	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
faster	NULL
migrating	NULL
bands	NULL
in	NULL
this	NULL
experiment	NULL
represent	NULL
nonspecifically	NULL
labeled	NULL
fusion	NULL
protein	NULL
as	NULL
judged	NULL
by	NULL
parallel	NULL
Coomassie	NULL
blue	NULL
staining	NULL
.	NULL

tative	NULL
assay	NULL
that	NULL
directly	NULL
measures	NULL
apoptosis	NULL
,	NULL
showed	NULL
similar	NULL
results	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
establish	NULL
that	NULL
the	NULL
mechanism	NULL
of	NULL
death	NULL
was	NULL
indeed	NULL
via	NULL
apoptosis	NULL
,	NULL
we	NULL
evaluated	NULL
fragmentation	NULL
of	NULL
total	NULL
cellular	NULL
DNA	NULL
into	NULL
characteristic	NULL
200-bp	NULL
concatamers	NULL
.	NULL

The	NULL
three	NULL
cell	NULL
types	NULL
were	NULL
stimulated	NULL
as	NULL
above	NULL
followed	NULL
by	NULL
lysis	NULL
and	NULL
DNA	NULL
precipitation	NULL
.	NULL

DNA	NULL
samples	NULL
from	NULL
unstimulated	NULL
and	NULL
Fas	NULL
stimulated	NULL
Jurkat	NULL
,	NULL
J45.01	NULL
,	NULL
and	NULL
JCaM.1	NULL
cells	NULL
were	NULL
then	NULL
separated	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
and	NULL
visualized	NULL
with	NULL
ethidium	NULL
bromide	NULL
staining	NULL
(	NULL
Fig	NULL
2B	NULL
)	NULL
.	NULL

We	NULL
observed	NULL
DNA	NULL
fragmentation	NULL
after	NULL
Fas	NULL
stimulation	NULL
in	NULL
all	NULL
three	NULL
cell	NULL
types	NULL
,	NULL
establishing	NULL
apoptosis	NULL
as	NULL
the	NULL
mechanism	NULL
of	NULL
death	NULL
.	NULL

Fas	NULL
cross-linking	NULL
results	NULL
in	NULL
JNK	NULL
activation	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Previous	NULL
work	NULL
has	NULL
documented	NULL
JNK	NULL
activation	NULL
in	NULL
cellular	NULL
responses	NULL
to	NULL
stimuli	NULL
,	NULL
including	NULL
osmotic	NULL
stress	NULL
,	NULL
``	NULL
``	NULL
treatment	NULL
with	NULL
protein	NULL
synthesis	NULL
inhibitors	NULL
,	NULL
``	NULL
and	NULL
TNF-receptor	NULL
stimulation	NULL
.	NULL

``	NULL
``	NULL
``	NULL
*	NULL
In	NULL
an	NULL
effort	NULL
to	NULL
elucidate	NULL
potential	NULL
signaling	NULL
mechanisms	NULL
and	NULL
to	NULL
confirm	NULL
that	NULL
CD45	NULL
and	NULL
Lck	NULL
were	NULL
not	NULL
required	NULL
for	NULL
Fas	NULL
signaling	NULL
pathways	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
ability	NULL
of	NULL
Fas	NULL
stimulation	NULL
to	NULL
activate	NULL
JNK	NULL
in	NULL
the	NULL
three	NULL
cell	NULL
lines	NULL
:	NULL
Jurkat	NULL
,	NULL
145.01	NULL
,	NULL
and	NULL
JCaM.1	NULL
.	NULL

Cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
with	NULL
Fas	NULL
MoAb	NULL
or	NULL
30	NULL
minutes	NULL
with	NULL
sorbitol	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
GST	NULL
c-Jun	NULL
fusion	NULL
protein	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
an	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
y-Reaction	NULL
products	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
assessed	NULL
by	NULL
autoradiography	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
3	NULL
,	NULL
all	NULL
three	NULL
cell	NULL
lines	NULL
responded	NULL
similarly	NULL
to	NULL
Fas	NULL
stimulation	NULL
by	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

LATINIS	NULL
AND	NULL
KORETZKY	NULL
Fig	NULL
4	NULL
.	NULL

JNK	NULL
is	NULL
activated	NULL
in	NULL
Jur-	NULL
kat	NULL
after	NULL
anti-Fas	NULL
and	NULL
C2-cera-	NULL
874	NULL
&	NULL
&	NULL
m	NULL
0	NULL
â	NULL
0	NULL
&	NULL
R	NULL
ago	NULL
G	NULL
Q0	NULL
Â«	NULL
9Â°	NULL
V	NULL
+	NULL
Â¢	NULL
-	NULL
.ot	NULL
C	NULL
Â£	NULL
~	NULL
9	NULL
r	NULL
1	NULL
I	NULL
wits	NULL
=	NULL
amas	NULL
awan	NULL
-	NULL
AWD	NULL
Â«	NULL
-	NULL
CSTcSun	NULL
30Â°	NULL
2	NULL
'	NULL
10Â°	NULL
30Â°	NULL
2Â°	NULL
1	NULL
gradually	NULL
increasing	NULL
JNK	NULL
activation	NULL
as	NULL
measured	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
coprecipitating	NULL
JNK	NULL
to	NULL
phosphorylate	NULL
GST	NULL
c-Jun	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
Fas	NULL
specifically	NULL
activates	NULL
JNK	NULL
in	NULL
a	NULL
CD45-	NULL
and	NULL
Leck-independent	NULL
fashion	NULL
.	NULL

C2-ceramide	NULL
induces	NULL
JNK	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Re-cently	NULL
,	NULL
others	NULL
have	NULL
reported	NULL
a	NULL
role	NULL
for	NULL
sphingomyelinase	NULL
activation	NULL
and	NULL
subsequent	NULL
ceramide	NULL
release	NULL
in	NULL
Fas-mediated	NULL
apoptosis	NULL
.	NULL

``	NULL
``	NULL
``	NULL
``	NULL
*	NULL
In	NULL
an	NULL
effort	NULL
to	NULL
establish	NULL
a	NULL
temporal	NULL
relationship	NULL
between	NULL
ceramide	NULL
release	NULL
and	NULL
JNK	NULL
activation	NULL
we	NULL
used	NULL
the	NULL
synthetic	NULL
ceramide	NULL
analog	NULL
,	NULL
C2-ceramide	NULL
,	NULL
to	NULL
stimulate	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

C2-ceramide	NULL
has	NULL
been	NULL
shown	NULL
previously	NULL
to	NULL
promote	NULL
apoptosis	NULL
in	NULL
T	NULL
cells	NULL
comparable	NULL
to	NULL
Fas	NULL
ligation	NULL
.	NULL
``	NULL

Cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
with	NULL
C2-ceramide	NULL
or	NULL
Fas	NULL
MoAb	NULL
or	NULL
30	NULL
minutes	NULL
with	NULL
sorbitol	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

JNK	NULL
activity	NULL
was	NULL
determined	NULL
as	NULL
above	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
4	NULL
,	NULL
stimulation	NULL
with	NULL
ceramide	NULL
analogs	NULL
resulted	NULL
in	NULL
JNK	NULL
activation	NULL
with	NULL
kinetics	NULL
similar	NULL
to	NULL
Fas	NULL
stimulation	NULL
.	NULL

J45.01	NULL
and	NULL
JCaM.1	NULL
cells	NULL
also	NULL
responded	NULL
similarly	NULL
to	NULL
C2-ceramide	NULL
stimulation	NULL
by	NULL
activating	NULL
JNK	NULL
and	NULL
stimulating	NULL
apoptosis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Efficient	NULL
signaling	NULL
through	NULL
the	NULL
TCR	NULL
requires	NULL
CD45	NULL
and	NULL
Lock	NULL
to	NULL
provide	NULL
proximal	NULL
tyrosine	NULL
phosphorylation	NULL
events	NULL
leading	NULL
to	NULL
distal	NULL
proliferative	NULL
responses	NULL
.	NULL

'*	NULL
``	NULL
Several	NULL
recent	NULL
reports	NULL
have	NULL
suggested	NULL
that	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
and	NULL
phosphatases	NULL
also	NULL
function	NULL
in	NULL
regulating	NULL
signaling	NULL
events	NULL
through	NULL
the	NULL
Fas	NULL
surface	NULL
receptor	NULL
.	NULL

``	NULL
``	NULL
``	NULL
Â°	NULL
The	NULL
present	NULL
study	NULL
was	NULL
designed	NULL
to	NULL
test	NULL
whether	NULL
the	NULL
tyrosine	NULL
phosphatase	NULL
,	NULL
CD45	NULL
,	NULL
and	NULL
the	NULL
lymphocyte-specific	NULL
Sre	NULL
family	NULL
kinase	NULL
,	NULL
Lok	NULL
,	NULL
also	NULL
are	NULL
important	NULL
for	NULL
Fas-induced	NULL
signals	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
CD45	NULL
and	NULL
Lock	NULL
are	NULL
not	NULL
required	NULL
for	NULL
Fas-induced	NULL
apoptosis	NULL
,	NULL
suggesting	NULL
that	NULL
TCR	NULL
proliferative	NULL
signals	NULL
and	NULL
Fas	NULL
apoptotic	NULL
signals	NULL
do	NULL
not	NULL
share	NULL
all	NULL
of	NULL
the	NULL
same	NULL
proximal	NULL
signaling	NULL
mechanisms	NULL
.	NULL

As	NULL
others	NULL
have	NULL
reported	NULL
,	NULL
``	NULL
``	NULL
we	NULL
observed	NULL
that	NULL
Fas	NULL
stimulation	NULL
of	NULL
Jurkat	NULL
results	NULL
in	NULL
some	NULL
PTK	NULL
activation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
our	NULL
hands	NULL
the	NULL
intensity	NULL
and	NULL
quantity	NULL
of	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
was	NULL
much	NULL
lower	NULL
than	NULL
with	NULL
TCR	NULL
stimulation	NULL
.	NULL

Interestingly	NULL
,	NULL
in	NULL
both	NULL
145.01	NULL
and	NULL
JCaM.1	NULL
Fas	NULL
ligation	NULL
resulted	NULL
in	NULL
no	NULL
detectable	NULL
changes	NULL
in	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
even	NULL
though	NULL
apoptosis	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
with	NULL
Jurkat	NULL
.	NULL

Several	NULL
recent	NULL
reports	NULL
have	NULL
illustrated	NULL
increases	NULL
in	NULL
JNK	NULL
activity	NULL
after	NULL
stress	NULL
activation	NULL
,	NULL
``	NULL
``	NULL
``	NULL
'	NULL
including	NULL
treatment	NULL
with	NULL
TNF	NULL
.	NULL
``	NULL

Our	NULL
experiments	NULL
similarly	NULL
showed	NULL
that	NULL
JNK	NULL
activity	NULL
increases	NULL
after	NULL
Fas	NULL
stimulation	NULL
.	NULL

Formal	NULL
proof	NULL
that	NULL
JNK	NULL
acti-	NULL
OI	NULL
mide	NULL
stimulation	NULL
.	NULL

Cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
anti-Fas	NULL
MoAb	NULL
,	NULL
C2-ceramide	NULL
,	NULL
or	NULL
sorbitol	NULL
,	NULL
and	NULL
JNK	NULL
enzymatic	NULL
activity	NULL
was	NULL
assessed	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
3	NULL
.	NULL

30	NULL
'	NULL
vation	NULL
participates	NULL
in	NULL
the	NULL
events	NULL
directly	NULL
inducing	NULL
apoptosis	NULL
requires	NULL
further	NULL
testing	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
intriguing	NULL
to	NULL
speculate	NULL
that	NULL
Fas	NULL
stimulation	NULL
triggers	NULL
a	NULL
signaling	NULL
cascade	NULL
similar	NULL
to	NULL
previously	NULL
described	NULL
stress-induced	NULL
pathways	NULL
.	NULL

One	NULL
known	NULL
function	NULL
of	NULL
JNK	NULL
is	NULL
to	NULL
phosphorylate	NULL
and	NULL
activate	NULL
the	NULL
transcription	NULL
factor	NULL
c-Jun	NULL
.	NULL
``	NULL

Although	NULL
some	NULL
reports	NULL
demonstrate	NULL
that	NULL
Fas-mediated	NULL
apoptosis	NULL
does	NULL
not	NULL
require	NULL
new	NULL
protein	NULL
synthesis	NULL
,	NULL
``	NULL
this	NULL
does	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
transcriptional	NULL
activation	NULL
still	NULL
participates	NULL
in	NULL
signaling	NULL
apoptosis	NULL
.	NULL

Experiments	NULL
are	NULL
currently	NULL
in	NULL
progress	NULL
to	NULL
test	NULL
the	NULL
significance	NULL
of	NULL
Fas-mediated	NULL
JNK	NULL
activation	NULL
and	NULL
whether	NULL
transcriptional	NULL
regulation	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
Fas	NULL
killing	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
show	NULL
also	NULL
that	NULL
a	NULL
synthetic	NULL
ceramide	NULL
analog	NULL
can	NULL
stimulate	NULL
JNK	NULL
activity	NULL
with	NULL
kinetics	NULL
similar	NULL
to	NULL
Fas	NULL
stimulation	NULL
.	NULL

This	NULL
observation	NULL
,	NULL
together	NULL
with	NULL
prior	NULL
reports	NULL
that	NULL
Fas	NULL
stimulates	NULL
ceramide	NULL
release	NULL
,	NULL
``	NULL
``	NULL
``	NULL
'	NULL
suggests	NULL
that	NULL
ceramide	NULL
release	NULL
may	NULL
occur	NULL
proximal	NULL
to	NULL
JNK	NULL
activation	NULL
in	NULL
the	NULL
Fas	NULL
signaling	NULL
cascade	NULL
.	NULL

We	NULL
are	NULL
pursuing	NULL
this	NULL
finding	NULL
in	NULL
our	NULL
effort	NULL
to	NULL
understand	NULL
more	NULL
fully	NULL
the	NULL
signaling	NULL
events	NULL
that	NULL
occur	NULL
linking	NULL
Fas	NULL
engagement	NULL
with	NULL
cellular	NULL
death	NULL
via	NULL
apoptosis	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Itoh	NULL
N	NULL
,	NULL
Yonehara	NULL
S	NULL
,	NULL
Ishii	NULL
A	NULL
,	NULL
Yonehara	NULL
M	NULL
,	NULL
Mizushima	NULL
S	NULL
,	NULL
Sameshima	NULL
M	NULL
,	NULL
Hase	NULL
A	NULL
,	NULL
Seto	NULL
Y	NULL
,	NULL
Nagata	NULL
S	NULL
:	NULL
The	NULL
polypeptide	NULL
encoded	NULL
by	NULL
the	NULL
cDNA	NULL
for	NULL
human	NULL
cell	NULL
surface	NULL
antigen	NULL
Fas	NULL
can	NULL
mediate	NULL
apoptosis	NULL
.	NULL

Cell	NULL
66:233	NULL
,	NULL
1991	NULL
2	NULL
.	NULL

Ochm	NULL
A	NULL
,	NULL
Behrmann	NULL
I	NULL
,	NULL
Falk	NULL
W	NULL
,	NULL
Pawlita	NULL
M	NULL
,	NULL
Maier	NULL
G	NULL
,	NULL
Klas	NULL
C	NULL
,	NULL
Li-Weber	NULL
M	NULL
,	NULL
Richards	NULL
$	NULL
,	NULL
Dhein	NULL
J	NULL
,	NULL
Trauth	NULL
BC	NULL
,	NULL
Ponsting	NULL
H	NULL
,	NULL
Krammer	NULL
PH	NULL
:	NULL
Purification	NULL
and	NULL
molecular	NULL
cloning	NULL
of	NULL
the	NULL
APO-1	NULL
cell	NULL
surface	NULL
antigen	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor/nerve	NULL
growth	NULL
factor	NULL
superfamily	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
267:10709	NULL
,	NULL
1992	NULL
3	NULL
.	NULL

Yonehara	NULL
S	NULL
,	NULL
Ishii	NULL
A	NULL
,	NULL
Yonehara	NULL
M	NULL
:	NULL
A	NULL
cell-killing	NULL
monoclonal	NULL
antibody	NULL
(	NULL
anti-Fas	NULL
)	NULL
to	NULL
a	NULL
cell	NULL
surface	NULL
antigen	NULL
co-downregulated	NULL
with	NULL
the	NULL
receptor	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
169:1747	NULL
,	NULL
1989	NULL
4	NULL
.	NULL

Trauth	NULL
BC	NULL
,	NULL
Klas	NULL
C	NULL
,	NULL
Peters	NULL
AMJ	NULL
,	NULL
Matzku	NULL
S	NULL
,	NULL
Moller	NULL
P	NULL
,	NULL
Falk	NULL
W	NULL
,	NULL
Debatin	NULL
K-M	NULL
,	NULL
Krammer	NULL
PH	NULL
:	NULL
Monoclonal	NULL
antibody-mediated	NULL
tumor	NULL
regression	NULL
by	NULL
induction	NULL
of	NULL
apoptosis	NULL
.	NULL

Science	NULL
245:301	NULL
,	NULL
1989	NULL
5	NULL
.	NULL

Suda	NULL
T	NULL
,	NULL
Takahashi	NULL
T	NULL
,	NULL
Golstein	NULL
P	NULL
,	NULL
Nagata	NULL
S	NULL
:	NULL
Molecular	NULL
cloning	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
Fas	NULL
ligand	NULL
,	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
family	NULL
.	NULL

Cell	NULL
75:1169	NULL
,	NULL
1993	NULL
6	NULL
.	NULL

Owen-Schaub	NULL
LB	NULL
,	NULL
Yonehara	NULL
S	NULL
,	NULL
Crump	NULL
WL	NULL
III	NULL
,	NULL
Grimm	NULL
EA	NULL
:	NULL
DNA	NULL
fragmentation	NULL
and	NULL
cell	NULL
death	NULL
is	NULL
selectively	NULL
triggered	NULL
in	NULL
activated	NULL
human	NULL
lymphocytes	NULL
by	NULL
Fas	NULL
antigen	NULL
engagement	NULL
.	NULL

Cell	NULL
Immunol	NULL
140:197	NULL
,	NULL
1992	NULL
7	NULL
.	NULL

Schulze-Osthoff	NULL
K	NULL
,	NULL
Walczak	NULL
H	NULL
,	NULL
Droge	NULL
W	NULL
,	NULL
Krammer	NULL
PH	NULL
:	NULL
Cell	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Fas	NULL
SIGNALING	NULL
DOES	NULL
NOT	NULL
REQUIRE	NULL
CD45	NULL
OR	NULL
Lck	NULL
nucleus	NULL
and	NULL
DNA	NULL
fragmentation	NULL
are	NULL
not	NULL
required	NULL
for	NULL
apoptosis	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
127:15	NULL
,	NULL
1994	NULL
8	NULL
.	NULL

Watanabe-Fukunaga	NULL
R	NULL
,	NULL
Brannan	NULL
CI	NULL
,	NULL
Copeland	NULL
NG	NULL
,	NULL
Jenkins	NULL
NA	NULL
,	NULL
Nagata	NULL
S	NULL
:	NULL
Lymphoproliferation	NULL
disorder	NULL
in	NULL
mice	NULL
explained	NULL
by	NULL
defects	NULL
in	NULL
Fas	NULL
antigen	NULL
that	NULL
mediates	NULL
apoptosis	NULL
.	NULL

Nature	NULL
356:314	NULL
,	NULL
1992	NULL
9	NULL
.	NULL

Takahashi	NULL
T	NULL
,	NULL
Tanaka	NULL
M	NULL
,	NULL
Brannan	NULL
CI	NULL
,	NULL
Jenkins	NULL
NA	NULL
,	NULL
Copeland	NULL
NG	NULL
,	NULL
Suda	NULL
T	NULL
,	NULL
Nagata	NULL
S	NULL
:	NULL
Generalized	NULL
lymphoproliferative	NULL
disease	NULL
in	NULL
mice	NULL
,	NULL
caused	NULL
by	NULL
a	NULL
point	NULL
mutation	NULL
in	NULL
Fas	NULL
ligand	NULL
.	NULL

Cell	NULL
76:969	NULL
,	NULL
1994	NULL
10	NULL
.	NULL

Fisher	NULL
GH	NULL
,	NULL
Rosenberg	NULL
FJ	NULL
,	NULL
Straus	NULL
SE	NULL
,	NULL
Dale	NULL
JK	NULL
,	NULL
Middleton	NULL
LA	NULL
,	NULL
Lin	NULL
AY	NULL
,	NULL
Strober	NULL
W	NULL
,	NULL
Lenardo	NULL
MJ	NULL
,	NULL
Puck	NULL
JM	NULL
:	NULL
Dominant	NULL
interfering	NULL
Fas	NULL
gene	NULL
mutations	NULL
impair	NULL
apoptosis	NULL
in	NULL
a	NULL
human	NULL
autoimmune	NULL
lymphoproliferative	NULL
syndrome	NULL
.	NULL

Cell	NULL
81:935	NULL
,	NULL
1995	NULL
11	NULL
.	NULL

Singer	NULL
GG	NULL
,	NULL
Abbas	NULL
AK	NULL
:	NULL
The	NULL
Fas	NULL
antigen	NULL
is	NULL
involved	NULL
in	NULL
peripheral	NULL
but	NULL
not	NULL
thymic	NULL
deletion	NULL
of	NULL
T	NULL
lymphocytes	NULL
in	NULL
T	NULL
cell	NULL
receptor	NULL
transgenic	NULL
mice	NULL
.	NULL

Immunity	NULL
1:365	NULL
,	NULL
1994	NULL
12	NULL
.	NULL

Watanabe-Fukunaga	NULL
R	NULL
,	NULL
Brannan	NULL
CI	NULL
,	NULL
Itoh	NULL
N	NULL
,	NULL
Yonehara	NULL
S	NULL
,	NULL
Copeland	NULL
NG	NULL
,	NULL
Jenkins	NULL
NA	NULL
,	NULL
Nagata	NULL
S	NULL
:	NULL
The	NULL
cDNA	NULL
structure	NULL
,	NULL
expres-sion	NULL
,	NULL
and	NULL
chromosomal	NULL
assignment	NULL
of	NULL
the	NULL
mouse	NULL
Fas	NULL
antigen	NULL
.	NULL

J	NULL
Immunol	NULL
148:1274	NULL
,	NULL
1992	NULL
13	NULL
.	NULL

Banner	NULL
DW	NULL
,	NULL
D'Arcy	NULL
A	NULL
,	NULL
Janes	NULL
W	NULL
,	NULL
Gentz	NULL
R	NULL
,	NULL
Schoenfeld	NULL
H-J	NULL
,	NULL
Broger	NULL
C	NULL
,	NULL
Loetscher	NULL
H	NULL
,	NULL
Lesslauer	NULL
W	NULL
:	NULL
Crystal	NULL
structure	NULL
of	NULL
the	NULL
soluble	NULL
human	NULL
55	NULL
kd	NULL
TNF	NULL
receptor-human	NULL
TNFS	NULL
complex	NULL
:	NULL
Implications	NULL
for	NULL
TNF	NULL
receptor	NULL
activation	NULL
.	NULL

Cell	NULL
73:431	NULL
,	NULL
1993	NULL
14	NULL
.	NULL

Itoh	NULL
N	NULL
,	NULL
Nagata	NULL
S	NULL
:	NULL
A	NULL
novel	NULL
protein	NULL
domain	NULL
required	NULL
for	NULL
apoptosis	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
268:10932	NULL
,	NULL
1993	NULL
15	NULL
.	NULL

Sato	NULL
T	NULL
,	NULL
Irie	NULL
S	NULL
,	NULL
Kitada	NULL
S	NULL
,	NULL
Reed	NULL
JC	NULL
:	NULL
FAP-1	NULL
:	NULL
A	NULL
protein	NULL
tyrosine	NULL
phosphatase	NULL
that	NULL
associates	NULL
with	NULL
Fas	NULL
.	NULL

Science	NULL
268:411	NULL
,	NULL
1995	NULL
16	NULL
.	NULL

Stanger	NULL
BZ	NULL
,	NULL
Leder	NULL
P	NULL
,	NULL
Lee	NULL
T-H	NULL
,	NULL
Kim	NULL
E	NULL
,	NULL
Seed	NULL
B	NULL
:	NULL
RIP	NULL
:	NULL
A	NULL
novel	NULL
protein	NULL
containing	NULL
a	NULL
death	NULL
domain	NULL
that	NULL
interacts	NULL
with	NULL
Fas/APO-1	NULL
(	NULL
CD95	NULL
)	NULL
in	NULL
yeast	NULL
and	NULL
causes	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
81:513	NULL
,	NULL
1995	NULL
17	NULL
.	NULL

Chinnaiyan	NULL
AM	NULL
,	NULL
O'Rourke	NULL
K	NULL
,	NULL
Tewari	NULL
M	NULL
,	NULL
Dixit	NULL
VM	NULL
:	NULL
FADD	NULL
,	NULL
a	NULL
novel	NULL
death	NULL
domain-containing	NULL
protein	NULL
,	NULL
interacts	NULL
with	NULL
the	NULL
death	NULL
domain	NULL
of	NULL
Fas	NULL
and	NULL
initiates	NULL
apoptosis	NULL
.	NULL

Cell	NULL
81:505	NULL
,	NULL
1995	NULL
18	NULL
.	NULL

Pingel	NULL
JT	NULL
,	NULL
Thomas	NULL
ML	NULL
:	NULL
Evidence	NULL
that	NULL
the	NULL
leukocyte-common	NULL
antigen	NULL
is	NULL
required	NULL
for	NULL
antigen-induced	NULL
T	NULL
lymphocyte	NULL
proliferation	NULL
.	NULL

Cell	NULL
58:1055	NULL
,	NULL
1989	NULL
19	NULL
.	NULL

Koretzky	NULL
GA	NULL
,	NULL
Kohmetscher	NULL
MA	NULL
,	NULL
Kadleck	NULL
T	NULL
,	NULL
Weiss	NULL
A	NULL
:	NULL
Restoration	NULL
of	NULL
T	NULL
cell	NULL
receptor-mediated	NULL
signal	NULL
transduction	NULL
by	NULL
transfection	NULL
of	NULL
CD45	NULL
cDNA	NULL
into	NULL
a	NULL
CD4S5-deficient	NULL
variant	NULL
of	NULL
the	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
.	NULL

J	NULL
Immunol	NULL
149:1138	NULL
,	NULL
1992	NULL
20	NULL
.	NULL

Koretzky	NULL
GA	NULL
,	NULL
Picus	NULL
J	NULL
,	NULL
Schultz	NULL
T	NULL
,	NULL
Weiss	NULL
A	NULL
:	NULL
Tyrosine	NULL
phosphatase	NULL
CD45	NULL
is	NULL
required	NULL
for	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
and	NULL
CD2-mediated	NULL
activation	NULL
of	NULL
a	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
and	NULL
interleukin	NULL
2	NULL
production	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:2037	NULL
,	NULL
1991	NULL
21	NULL
.	NULL

Volarevic	NULL
S	NULL
,	NULL
Niklinska	NULL
BB	NULL
,	NULL
Burns	NULL
CM	NULL
,	NULL
June	NULL
CH	NULL
,	NULL
Weissman	NULL
AM	NULL
,	NULL
Ashwell	NULL
JD	NULL
:	NULL
Regulation	NULL
of	NULL
TCR	NULL
signaling	NULL
by	NULL
CD45	NULL
lacking	NULL
transmembrane	NULL
and	NULL
extracellular	NULL
domains	NULL
.	NULL

Science	NULL
260:541	NULL
,	NULL
1993	NULL
22	NULL
.	NULL

Hovis	NULL
RR	NULL
,	NULL
Donovan	NULL
JA	NULL
,	NULL
Musci	NULL
MA	NULL
,	NULL
Motto	NULL
DG	NULL
,	NULL
Goldman	NULL
FD	NULL
,	NULL
Ross	NULL
SE	NULL
,	NULL
Koretzky	NULL
GA	NULL
:	NULL
Rescue	NULL
of	NULL
signaling	NULL
by	NULL
a	NULL
chimeric	NULL
protein	NULL
containing	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
CD45	NULL
.	NULL

Science	NULL
260:544	NULL
,	NULL
1993	NULL
23	NULL
.	NULL

Straus	NULL
DB	NULL
,	NULL
Weiss	NULL
A	NULL
:	NULL
Genetic	NULL
evidence	NULL
for	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
Ick	NULL
tyrosine	NULL
kinase	NULL
in	NULL
signal	NULL
transduction	NULL
through	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
.	NULL

Cell	NULL
70:585	NULL
,	NULL
1992	NULL
875	NULL
24	NULL
.	NULL

Molina	NULL
TJ	NULL
,	NULL
Kishihara	NULL
K	NULL
,	NULL
Siderovski	NULL
DP	NULL
,	NULL
van	NULL
Ewijk	NULL
W	NULL
,	NULL
Naren-dran	NULL
A	NULL
,	NULL
Timms	NULL
E	NULL
,	NULL
Wakeham	NULL
A	NULL
,	NULL
Paige	NULL
CJ	NULL
,	NULL
Hartmann	NULL
K-U	NULL
,	NULL
Veillette	NULL
A	NULL
,	NULL
Davidson	NULL
D	NULL
,	NULL
Mak	NULL
TW	NULL
:	NULL
Profound	NULL
block	NULL
in	NULL
thymocyte	NULL
development	NULL
in	NULL
mice	NULL
lacking	NULL
p56	NULL
``	NULL
.	NULL

Nature	NULL
357:161	NULL
,	NULL
1992	NULL
25	NULL
.	NULL

Levin	NULL
SD	NULL
,	NULL
Anderson	NULL
SJ	NULL
,	NULL
Forbush	NULL
KA	NULL
,	NULL
Perlmutter	NULL
RM	NULL
:	NULL
A	NULL
dominant-negative	NULL
transgene	NULL
defines	NULL
a	NULL
role	NULL
for	NULL
p56	NULL
``	NULL
in	NULL
thymo-poiesis	NULL
.	NULL

EMBO	NULL
J	NULL
12:1671	NULL
,	NULL
1993	NULL
26	NULL
.	NULL

Eischen	NULL
CM	NULL
,	NULL
Dick	NULL
CJ	NULL
,	NULL
Leibson	NULL
PJ	NULL
:	NULL
Tyrosine	NULL
kinase	NULL
activation	NULL
provides	NULL
an	NULL
early	NULL
and	NULL
requisite	NULL
signal	NULL
for	NULL
Fas-induced	NULL
apoptosis	NULL
.	NULL

J	NULL
Immunol	NULL
153:1947	NULL
,	NULL
1994	NULL
27	NULL
.	NULL

Sluss	NULL
HK	NULL
,	NULL
Barrett	NULL
T	NULL
,	NULL
Derijard	NULL
B	NULL
,	NULL
Davis	NULL
RJ	NULL
:	NULL
Signal	NULL
transduction	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
mediated	NULL
by	NULL
JNK	NULL
protein	NULL
kinases	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:8376	NULL
,	NULL
1994	NULL
28	NULL
.	NULL

Cifone	NULL
MG	NULL
,	NULL
De	NULL
Maria	NULL
R	NULL
,	NULL
Roncaioli	NULL
P	NULL
,	NULL
Rippo	NULL
MR	NULL
,	NULL
Azuma	NULL
M	NULL
,	NULL
Lanier	NULL
LL	NULL
,	NULL
Santoni	NULL
A	NULL
,	NULL
Testi	NULL
R	NULL
:	NULL
Apoptotic	NULL
signaling	NULL
through	NULL
CD95	NULL
(	NULL
Fas/APO-1	NULL
)	NULL
activates	NULL
an	NULL
acidic	NULL
sphingomyelinase	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
177:1547	NULL
,	NULL
1993	NULL
29	NULL
.	NULL

Kim	NULL
M-Y	NULL
,	NULL
Linardic	NULL
C	NULL
,	NULL
Obeid	NULL
L	NULL
,	NULL
Hannun	NULL
Y	NULL
:	NULL
Identification	NULL
of	NULL
sphingomyelin	NULL
turnover	NULL
as	NULL
an	NULL
effector	NULL
mechanism	NULL
for	NULL
the	NULL
action	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
and	NULL
y-interferon	NULL
.	NULL

Specific	NULL
role	NULL
in	NULL
cell	NULL
differentiation	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
266:484	NULL
,	NULL
1991	NULL
30	NULL
.	NULL

Hannun	NULL
YA	NULL
:	NULL
The	NULL
sphingomyelin	NULL
cycle	NULL
and	NULL
the	NULL
second	NULL
messenger	NULL
function	NULL
of	NULL
ceramide	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
269:3125	NULL
,	NULL
1994	NULL
31	NULL
.	NULL

Tepper	NULL
CG	NULL
,	NULL
Jayadev	NULL
S	NULL
,	NULL
Liu	NULL
B	NULL
,	NULL
Bielawska	NULL
A	NULL
,	NULL
Wolff	NULL
R	NULL
,	NULL
Yonehara	NULL
S	NULL
,	NULL
Hannun	NULL
YA	NULL
,	NULL
Seldin	NULL
MF	NULL
:	NULL
Role	NULL
for	NULL
ceramide	NULL
as	NULL
an	NULL
endogenous	NULL
mediator	NULL
of	NULL
Fas-induced	NULL
cytotoxicity	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
92:8443	NULL
,	NULL
1995	NULL
32	NULL
.	NULL

Gulbins	NULL
E	NULL
,	NULL
Bissonnette	NULL
R	NULL
,	NULL
Mahboubi	NULL
A	NULL
,	NULL
Martin	NULL
S	NULL
,	NULL
Nishioka	NULL
W	NULL
,	NULL
Brunner	NULL
T	NULL
,	NULL
Baier	NULL
G	NULL
,	NULL
Baier-Bitterlich	NULL
G	NULL
,	NULL
Byrd	NULL
C	NULL
,	NULL
Lang	NULL
F	NULL
,	NULL
Koles-nick	NULL
R	NULL
,	NULL
Altman	NULL
A	NULL
,	NULL
Green	NULL
D	NULL
:	NULL
Fas-induced	NULL
apoptosis	NULL
is	NULL
mediated	NULL
via	NULL
a	NULL
ceramide-initiated	NULL
Ras	NULL
signaling	NULL
pathway	NULL
.	NULL

Immunity	NULL
2:41	NULL
,	NULL
1995	NULL
33	NULL
.	NULL

Smith	NULL
DB	NULL
,	NULL
Johnson	NULL
KS	NULL
:	NULL
Single-step	NULL
purification	NULL
of	NULL
polypep-tides	NULL
expressed	NULL
in	NULL
Escherichia	NULL
coli	NULL
as	NULL
fusions	NULL
with	NULL
glutathione	NULL
S-transferase	NULL
.	NULL

Gene	NULL
67:31	NULL
,	NULL
1988	NULL
34	NULL
.	NULL

Boise	NULL
LH	NULL
,	NULL
Minn	NULL
AJ	NULL
,	NULL
Noel	NULL
PJ	NULL
,	NULL
June	NULL
CH	NULL
,	NULL
Accavitti	NULL
MA	NULL
,	NULL
Linds-ten	NULL
T	NULL
,	NULL
Thompson	NULL
CB	NULL
:	NULL
CD28	NULL
costimulation	NULL
can	NULL
promote	NULL
T	NULL
cell	NULL
survival	NULL
by	NULL
enhancing	NULL
the	NULL
expression	NULL
of	NULL
Bel-x	NULL
;	NULL
,	NULL
.	NULL

Immunity	NULL
3:87	NULL
,	NULL
1995	NULL
35	NULL
.	NULL

Hibi	NULL
M	NULL
,	NULL
Lin	NULL
A	NULL
,	NULL
Smeal	NULL
T	NULL
,	NULL
Minden	NULL
A	NULL
,	NULL
Karin	NULL
M	NULL
:	NULL
Identification	NULL
of	NULL
an	NULL
oncoprotein-	NULL
and	NULL
UV-responsive	NULL
protein	NULL
kinase	NULL
that	NULL
binds	NULL
and	NULL
potentiates	NULL
the	NULL
c-Jun	NULL
activation	NULL
domain	NULL
.	NULL

Genes	NULL
Dev	NULL
7:2135	NULL
,	NULL
1993	NULL
36	NULL
.	NULL

Galcheva-Gargova	NULL
Z	NULL
,	NULL
Derijard	NULL
B	NULL
,	NULL
Wu	NULL
I-H	NULL
,	NULL
Davis	NULL
RJ	NULL
:	NULL
An	NULL
os-mosensing	NULL
signal	NULL
transduction	NULL
pathway	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Science	NULL
265:806	NULL
,	NULL
1994	NULL
37	NULL
.	NULL

Cano	NULL
E	NULL
,	NULL
Hazzalin	NULL
CA	NULL
,	NULL
Mahadevan	NULL
LC	NULL
:	NULL
Anisomycin-activated	NULL
protein	NULL
kinases	NULL
p45	NULL
and	NULL
p55	NULL
but	NULL
not	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
ERK-1	NULL
and	NULL
-2	NULL
are	NULL
implicated	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:7352	NULL
,	NULL
1994	NULL
38	NULL
.	NULL

Westwick	NULL
JK	NULL
,	NULL
Weitzel	NULL
C	NULL
,	NULL
Minden	NULL
A	NULL
,	NULL
Karin	NULL
M	NULL
,	NULL
Brenner	NULL
DA	NULL
:	NULL
Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
stimulates	NULL
AP-1	NULL
activity	NULL
through	NULL
prolonged	NULL
activation	NULL
of	NULL
the	NULL
c-Jun	NULL
kinase	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
269:26396	NULL
,	NULL
1994	NULL
39	NULL
.	NULL

Klas	NULL
C	NULL
,	NULL
Debatin	NULL
K-M	NULL
,	NULL
Jonker	NULL
RR	NULL
,	NULL
Krammer	NULL
PH	NULL
:	NULL
Activation	NULL
interferes	NULL
with	NULL
the	NULL
APO-1	NULL
pathway	NULL
in	NULL
mature	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Int	NULL
Immunol	NULL
5:625	NULL
,	NULL
1993	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

blood	NULL
Fas	NULL
ligation	NULL
induces	NULL
apoptosis	NULL
and	NULL
Jun	NULL
kinase	NULL
activation	NULL
independently	NULL
of	NULL
CD45	NULL
and	NULL
Lok	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
KM	NULL
Latinis	NULL
and	NULL
GA	NULL
Koretzky	NULL
4	NULL
peRiCAy	NULL
_	NULL
5	NULL
,	NULL
'	NULL
_	NULL
>	NULL
,	NULL
#	NULL
04	NULL
;	NULL
Â©1004	NULL
@	NULL
207	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/87/3/871	NULL
.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

